BlackRock Fund Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

BlackRock Fund Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$57K	Buy	6,415 +195	+3%	+$3.89K	﹤0.01%	3743
2016 Q3	$202K	Sell	6,220 -24	-0.4%	-$584	﹤0.01%	3448
2016 Q2	$115K	Sell	6,244 -26,472	-81%	-$470K	﹤0.01%	3633
2016 Q1	$546K	Sell	32,716 -1,807	-5%	-$36.2K	﹤0.01%	3229
2015 Q4	$1.07M	Buy	34,523 +4,558	+15%	+$156K	﹤0.01%	3229
2015 Q3	$1.55M	Buy	+29,965	New	+$1.97M	﹤0.01%	3164

Other funds holding ALPN

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Fund Advisors's ALPN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Alpine Immune Sciences Inc (ALPN) stake by 3.1% in Q4 2016, buying an estimated $3.89K and bringing the position to 6,415 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

BlackRock Fund Advisors first reported a position in ALPN in Q3 2015 and has held it in 6 quarters since. The position peaked at $1.55M in Q3 2015. 38 funds tracked by Wall St. Rank hold ALPN as of Q4 2016.

BlackRock Fund Advisors held 6,415 shares of Alpine Immune Sciences Inc worth $57K as of Q4 2016.
BlackRock Fund Advisors bought 195 Alpine Immune Sciences Inc shares in Q4 2016, an estimated $3.89K.
Alpine Immune Sciences Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3743 holding.
BlackRock Fund Advisors first reported a position in Alpine Immune Sciences Inc in Q3 2015 and has held it in 6 quarters since.
BlackRock Fund Advisors's Alpine Immune Sciences Inc position peaked at $1.55M in Q3 2015.
38 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.